St. Luke's International Hospital

Chūōku, Tokyo-to 104-8560

1 studies enrolling now · 4 studies all time

What they study most

Lupus Erythematosus, Systemic, Plaque Psoriasis, Primary Sjogrens Disease, Systemic Lupus Erythematosus

Studies at this site

• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK) — Recruiting now
• A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome — Running, not enrolling
• A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus — Running, not enrolling
• A Phase II Study of M2951 in SLE — Stopped early